Advertisement

Topics

Novo Nordisk pays $58.7m to settle claims of mis-selling liraglutide

12:16 EDT 8 Sep 2017 | British Medical Journal

The Danish drug company Novo Nordisk has paid $58.7m (£45m; €49m) to settle a cluster of seven US lawsuits accusing the company of deceptive sales practices, paying kickbacks to high prescribing...

Original Article: Novo Nordisk pays $58.7m to settle claims of mis-selling liraglutide

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk pays $58.7m to settle claims of mis-selling liraglutide"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...